Femasys (FEMY) Net Cash Flow Growth (1y) (2021 - 2026)
Femasys (FEMY) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -9.88% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 131.47% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -196.55% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 102.38% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -41.07% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 84.02% |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | -1,153.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,153.15% |
| Dec 31, 2025 | 212.93% |
| Sep 30, 2025 | 122.84% |
| Jun 30, 2025 | 86.03% |
| Mar 31, 2025 | 109.50% |
| Dec 31, 2024 | -131.94% |
| Sep 30, 2024 | -193.89% |
| Jun 30, 2024 | -892.76% |
| Mar 31, 2024 | -38.55% |
| Dec 31, 2023 | 527.89% |
| Sep 30, 2023 | 35.30% |
| Jun 30, 2023 | 120.51% |
| Mar 31, 2023 | 7.12% |
| Dec 31, 2022 | -21.88% |
| Sep 30, 2022 | -20.64% |
| Jun 30, 2022 | -109.52% |
| Mar 31, 2022 | -130.95% |
| Dec 31, 2021 | -100.78% |
| Sep 30, 2021 | -191.57% |